0001628280-16-021955.txt : 20161209
0001628280-16-021955.hdr.sgml : 20161209
20161209162103
ACCESSION NUMBER: 0001628280-16-021955
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20161207
FILED AS OF DATE: 20161209
DATE AS OF CHANGE: 20161209
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Bellerophon Therapeutics, Inc.
CENTRAL INDEX KEY: 0001600132
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 473116175
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 184 LIBERTY CORNER ROAD, SUITE 302
CITY: WARREN
STATE: NJ
ZIP: 07059
BUSINESS PHONE: 908-574-4770
MAIL ADDRESS:
STREET 1: 184 LIBERTY CORNER ROAD, SUITE 302
CITY: WARREN
STATE: NJ
ZIP: 07059
FORMER COMPANY:
FORMER CONFORMED NAME: Bellerophon Therapeutics LLC
DATE OF NAME CHANGE: 20140213
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Tenenbaum Fabian
CENTRAL INDEX KEY: 0001641300
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36845
FILM NUMBER: 162044298
MAIL ADDRESS:
STREET 1: 60 EAST 42ND STREET, SUITE 1160
CITY: NEW YORK
STATE: NY
ZIP: 10165
4
1
wf-form4_148131845009703.xml
FORM 4
X0306
4
2016-12-07
0
0001600132
Bellerophon Therapeutics, Inc.
BLPH
0001641300
Tenenbaum Fabian
184 LIBERTY CORNER ROAD
SUITE 302
WARREN
NJ
07059
0
1
0
0
Chief Executive Officer
Stock Option (right to buy)
0.49
2016-12-07
4
A
0
1042556
0
A
2026-12-06
Common Stock
1042556.0
1042556
D
The option grant was approved by Bellerophon Therapeutics, Inc.'s board of directors on December 7, 2016, subject to stockholder approval of an amendment to the stock option plan under which the option was granted.
/s/ Fabian Tenenbaum
2016-12-09